PM360 JUDGES ANNOUNCE WINNERS OF 2011 TRAILBLAZER AWARDS
Best of the Best in Healthcare Marketing Honored at Gala Event
NEW YORK, NY, Sept. 19, 2011: PM360, a leading health-marketing industry trade magazine, recognized the best innovators in the industry with their annual Trailblazer awards on Friday, September 9, 2011. The honors, bestowed at a gala banquet at the Mandarin Oriental Hotel, are given to outstanding companies, marketers and brand managers representing top talent and brands.

“Creativity and imagination are vital skills to success in our industry,” said Anna Stashower, president and publisher of PM360. “The companies and individuals receiving awards today have distinguished themselves as the leaders and thinkers who keep us moving forward. They well deserve our recognition, and our praise.”

This year’s winners continue the tradition of honoring pharma marketers for their exceptional forward thinking. PM360, is pleased to announce Rob Likoff, CEO of Group DCA, won the award for Marketer of the Year. The honor recognizes Mr. Likoff’s leadership, creativity and business judgment.

Entries are judged and winners selected by the PM360 Editorial Advisory Board, a cross section of experts from across the industry. Winning entries were judged based on content, format, success in reaching targeted audience, and overall quality, and distinguished themselves in their ability to stand out in the complex healthcare environment. The Marketer of the Year award singles out the individual who best exemplifies the most insightful, forward-thinking, and transformative marketing ideas and actions in the industry. PM360 will publish profiles of this year’s Trailblazer winners in a supplement to its October issue.

This year’s PM360 Trailblazer winners include:
Company of the Year Award:
Pharmaceutical: Johnson & Johnson

Medical Device: Kimberly-Clark Health Care

Advertising Agency: Dudnyk

Supplier/Vendor: Publicis Touchpoint

Marketer of the Year

Rob Likoff, CEO, Group DCA

Initiative Awards

App: Novo Nordisk and closerlook, NovoMedLink.pro mobileApp

Consumer Website/Online: Smith & Nephew and Beacon Healthcare, “My Knee and Me”

Direct Mail: Bristol-Myers Squibb, “One Patient at a Time”

Direct-to-Consumer Campaign: Acclarent and Roska,“Balloon Sinuplasty Campaign”

Direct-to-Patient Campaign: Boehringer Ingelheim and Everyday Health,
“Guide to Managing COPD”

Interactive Marketing: Amgen and Cell Division, Inc., Nplate Interactive Marketing Program

Persistence: Novo Nordisk and BrainWorks Communications,
“Improving Diabetes Care in the Pharmacy”

PR Campaign: Boehringer Ingelheim and Biosector 2, “DRIVE4COPD”

Product Launch: Takeda Canada and Abelson Taylor, Dexilant, “Tortoise and Hare”

Professional Campaign: Takeda and Abelson Taylor, Takeda Canada “Switches” Campaign

Professional Website/Online Initiative: Pfizer and Hudson Global,
“My Vaccine Resource” Website

Self-Promotion Category: Intouch Solutions, Intouchsol.com Redesign

Social Media Category: Sanofi and Intouch Solutions,
“Leveraging Social Media Engagement to Better Deliver on Patient Needs”

Unbranded Campaign: Boehringer Ingelheim and Biosector 2, “DRIVE4COPD”

Video Commercial: Allergan and Abelson Taylor, Restasis Interactive Learning Program

Brand Manager Awards

Autoimmune: Frank Nazzario of ViroPharma, Cinryze

Cardiology: Laura Seplavy of Bristol-Myers Squibb, Plavix

CNS: Bill Smith of Teva Neuroscience, Azilect

Dermatology: Kevin Kriel of Galderma, Epiduo Gel

Diabetes/Metabolic Diseases: Sara Aswegan of Shire Human Genetic Therapies

Gastrointestinal: Sheila Doyle of Mederi Therapeutics, Secca and Stretta

Hematology/Oncology: William Ragatz of Boehringer Ingelheim, Pradaxa

Infectious Diseases: Constantine Velentzas of Pfizer, Prevnar-13

Medical Device: Jennifer Barnard of Acclarent, Balloon Sinuplasty Technology

Men’s Health: Frank Jaeger of Abbott, AndroGel

Ophthalmology: Heather Drennan of Alcon Laboratories, AcrySof IQ IOLs

Pain/Inflammation: Jeff Dieckhaus of Alcon Laboratories, Durezol

Respiratory: Marc Sullivan of Boehringer Ingelheim, Spiriva

Women’s Health: Qasim Rizvi of Genentech, Herceptin and Pertuzumab

###

PM360 is the premier source for information that product managers and pharma marketing professionals need to succeed in the complex, ever-changing healthcare environment. PM360 offers invaluable perspective on important industry issues through a full-circle combination of how-to information and thoughtful career insights. The PM360 Trailblazer Awards span four categories, including Company of the Year, Marketer of the Year, Brand Manager Awards, and Initiative Awards.
***********
Click here to download the Press Release

HOT TOPICS
One Pill. Multiple Drugs
Pharma companies should start thinking about which of their drugs are made for each other, because they may soon be able to
deploy multiple therapies within one capsule. Researchers at the Georgia Institute of Technology have designed a multiple-compartment
gel capsule that can simultaneously deliver different types of drugs. The hydrogel capsules measure less than one micron and are prepared using a “one-pot” method, meaning the drugs would all be contained within the capsule’s hollow shell. The shell, however, is not completely empty.…
Image Is Important
Sure, self-image is important and all, but you can’t just discount how others perceive you—especially if you are a company trying to sell products. SDI’s Pharmaceutical Company Image 2011 study offers a comprehensive analysis of pharmaceutical company and industry image as perceived by key healthcare audiences. A total of 9,800 participants were surveyed in March and April 2011, including physicians from 27 specialties. Among those specialties are obstetricians/gynecologists and cardiologists. Four in ten OB/GYNs hold Pfizer in the highest esteem while Merck, last year’s leader, dropped to third..
Man-Made Organ
The recipe for a man-made trachea, or windpipe, is quite simple. Start with a glass tube, use some spongy plastic to give it the right shape, spin it like a rotisserie chicken while dripping on some yummy stem cells, add a little bit of growth hormone for taste, let everything marinate for two days, then insert into the patient and listen to him breathe. Best of all—this new organ can be ready in less than two weeks.
FDA UPDATE
An FDA panel unanimously agreed that Roche Holding’s Avastin should no longer be approved for the treatment of breast cancer. This decision followed a rare two-day hearing where several patient advocates tried to make the case for Avastin, but the panel ruled that the drug was not safe or clinically beneficial based on follow-up trials. The Centers for Medicare and Medicaid already released a statement saying that Medicare will continue to cover Avastin for breast cancer regardless of the FDA’s decision. FDA Commissioner Margaret Hamburg is expected to make a final decision later this year…

To Access ALL of PM360's Experts on Call Click Here!
FEATURES
PM360 COVER STORY: Turning Competitive Intelligence Into a Winning Strategy
By Jerry Maynor
The emergence of social media, evolving prescriber information demands, and new data sources makes this one of the most dynamic and challenging times to plan strategy for medical marketing. Here are some of the trends, and some approaches marketers can use to give their products the winning edge.
Feature: Strategic Priorities for Specialty Care Products
By Sanjay Rao
By 2013, specialty drugs will account for half of all pharmaceutical spending…and most of the industry’s growth. These complex, large-molecule products, though, demand sales and marketing approaches aimed at demonstrating positive outcomes.
Feature: Establishing Effective Co-Promotion Guidelines for a Successful Partnership
By Chuck McLeester
Co-promotions work when everybody knows what to do, when to do it, and wants the team to win. Here are eight guidelines that help joint ventures succeed.
Feature: The Paradigm Shift In Key-Opinion-Leader Marketing: A Brief
By Derek Evans and Rob Fellman
Expanded reporting requirements, especially the Sunshine Act, will accelerate the migration away from product-driven strategies and towards market-driven and evidenced-based approaches, changing the role of the key opinion leader.
THINK TANK: CRM Insights–Burnish Your Brand

We asked our experts to talk about new media, cross-channel campaigns, and what makes for successful physician customer-relationship management programs. With Leonard Bishop, Kelly Choi, MD, Dave Escalante, Pratap Khedkar, Dean Schwartz, and Brad Sitler.






PRODUCT MANAGER SURVEY
ABOUT OUR SPONSOR
Learn about the value e-Healthcare Solutions provides to pharmaceutical companies.
THANKS TO OUR RESPONDENTS FROM THESE COMPANIES
TODAY’S PRODUCT MANAGER
The survey’s methodology, its major themes, and a list of the companies represented.
RESPONDENT PROFILE
Educational background, professional experience, and brand experience.
CAREER DETAILS
Marketers share details about their salary, job satisfaction, and where they get the info to stay ahead of the game as well as the best places to go for new marketing ideas.
CAREERS HIGHS + LOWS
Respondents reveal their greatest achievements and failures in marketing.
THE ECONOMY
The effect the economy has had on pharmaceutical sales, marketing budgets, and budget allocation.
THE INDUSTRY
An overview of the factors that had the most impact on the industry in the past year and what will impact the industry in the upcoming year.
ALL ABOUT YOUR BRAND
How brands stack up against their fiercest competitors.
MARKETING MASTER PLAN
Everything from how marketers spend their time to the size of this year’s budgets, and how marketers allocate the money they do receive.
DIGITAL MEDIA
The hottest marketing trends, marketers’ use of social media, online advertising, and metrics for measuring success.
IN THIS ISSUE
The Case of the Ersatz Apple Store
Guest Commentary OTCs Richard G. Stafanacci, DO
Industry Briefs Pollsters merge, GSK moves sales incentive, and more
E-Source Serving Up What the Doctor Ordered–Effectively Rob Likoff
DTC 360 DTC's Talent Drain Richard Meyer
Common Sense Help Yourself, Help Your Kids Bud Bilanich
PR 360 No Free Lunch–Advocacy Strategy Comes of Age Gil Bashe
Healthcare Highlights An artificial trachea, a multi-drug pill, FDA Updates, and more
Life Style Green billboards, eco-offices, and more
Marketing Insider Phase 3C–"Market Approval" and the Soft Launch E.M. (Mick) Kolassa, PhD
Book Review The Mesh: Why the Future of Business Is Sharing, by Lisa Gansky Reviewed by Ramiro Roman
Cutting Edge Gadgets and gear for today's on-the-go professional
The Scene IdeaShare, San Francisco, June 29-July 3, 2011
Movers & Shakers Career changes in the industry
Calendar A quick reference list of upcoming industry events
PhotoFinish Health for Sale: Posters from the William H. Helfand Collection, Philadelphia Museum of Art

2011 Editorial Calendar Now Available!

Click Here to Download



White Paper: Drug Sample Acceptance Preferences in Medical Offices

Published by SK&A, A Cegedim Company

Learn which physicians accept and store drug samples at their office sites, and their preferences for receiving the sample packets from pharmaceutical sales reps. SK&A, A Cegedim Company’s recent telephone survey of nearly 170,000 U.S. medical offices reveals an average acceptance rate of 77 percent. Download this unique report to understand acceptance preferences by specialty, patient volume, practice size and ownership. Determine if your targets prefer to have drug samples dropped off, mailed or both.

Click Here to Download the White Paper



Site ©2008-2011 AMS Group LLC.

blog comments powered by Disqus